aTyr Pharma Inc. is a biotechnology company that develops therapeutics based on a new class of proteins called Physiocrines. Their innovative approach aims to address severe rare diseases and immune-mediated conditions by targeting the immune system’s inflammatory pathways. With their cutting-edge research, aTyr Pharma has the potential to make significant advancements in the treatment of these conditions.
